Skip Navigation


Journal of Biochemistry Advance Access originally published online on February 22, 2007
Journal of Biochemistry 2007 141(5):653-660; doi:10.1093/jb/mvm067
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrow All Versions of this Article:
141/5/653    most recent
mvm067v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sakiyama, R.
Right arrow Articles by Nakamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakiyama, R.
Right arrow Articles by Nakamura, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 The Japanese Biochemical Society.

Stimulation of Hepatocyte Growth Factor Production by Heparin-derived Oligosaccharides

Ryoichi Sakiyama1, Kazuhiro Fukuta1, Kunio Matsumoto1, Masumi Furukawa2, Yoshihiro Takahashi3 and Toshikazu Nakamura1,*

1Division of Molecular Regenerative Medicine, Department of Biochemistry and Molecular Biology, Osaka University Graduate School of Medicine, 2-2-B7 Yamadaoka, Suita, Osaka 565-0871; 2Osaka Laboratory, Sawai Pharmaceutical, Co., Ltd., 8-14 Ikue 1-Chome, Asahi-Ku, Osaka 535-0004; and 3Saito Laboratory, Kringle Pharma, Inc., 7-7-15 Saitoasagi, Ibaraki, Osaka 567-0085, Japan

*To whom the correspondence should be addressed. Tel: +81-6-6879-3783, Fax: +81-6-6879-3789, E-mail: nakamura{at}onbich.med.osaka-u.ac.jp

Received December 31, 2006; Accepted February 14, 2007


   Abstract

We previously reported that heparin post-transcriptionally stimulates the production of hepatocyte growth factor (HGF). In this study, we addressed the size-dependency of heparin fragments on the HGF-inducing activity aiming to obtain fragments without antiblood coagulant activity. Heparin fragments, produced by digestion with heparinase, were size-fractionated and tested for HGF-inducing activity in cultured human fibroblasts. The HGF-inducing activity deceased with the reduction in oligosaccharide size. Decasaccharides exerted an activity comparable with undigested heparin, while smaller oligosaccharides showed lesser activities. The anticoagulant activity of heparin fragments also decreased with size and anticoagulant activity of decasaccharides was <13% that of undigested heparin. Further fractionation of decasaccharides by anion-exchange chromatography revealed that most of the decasaccharides had HGF-inducing activity and the extent of sulfation was roughly related to the activity. The lack of N-sulfation in heparin markedly reduced HGF-inducing activity, whereas 2-O-desulfation or 6-O-desulation had a lesser influence. Moreover, an N-sulfated disaccharide showed significant HGF-inducing activity, suggesting the involvement of N-sulfation in HGF-inducing activity. Because of the much reduced anticoagulant activity, potential applications of heparin-derived oligosaccharides such as decasaccharides is considerable as a therapeutic agent for many diseases.

Key Words: glycosaminoglycan, heparan sulfate, heparin, HGF, oligosaccharide

Abbreviations: HGF, hepatocyte growth factor; HS, heparan sulfate; DMEM, Dulbecco's modified Eagle's medium; FCS, fetal calf serum; UA, hexuronic acid; {Delta}UA, {Delta}4,5 unsaturated hexuronic acid; GlcN, N-unsubstituted glucosamine; GlcNS, N-sulfated glucosamine; GlcNAc, N-acetylglucosamine; 2S, 2-O-sulfate; 6S, 6-O-sulfate


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
G Ferraccioli and G Romano
Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors
Lupus, June 1, 2008; 17(6): 533 - 540.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.